Cargando…

Antinociceptive Effects of Shenling Baizhu through PI3K-Akt-mTOR Signaling Pathway in a Mouse Model of Bone Metastasis with Small-Cell Lung Cancer

Shenling Baizhu additive powder (SLBZ-AP), a formulation of a variety of natural medicinal plants, has clinical efficacy in treating cancers in previous studies. We explored the effect of SLBZ-AP in bone metastasis of lung cancer (BMLC) mice, and the possible mechanism involved was further investiga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Zhe, Feng, Ziyi, Han, Jie, Cheng, Weimin, Su, Bo, Mo, Jian, Feng, XinJian, Feng, Sitan, Chen, GuoJian, Huang, Peng, Huang, Long, Cui, Zhenwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327581/ https://www.ncbi.nlm.nih.gov/pubmed/32655659 http://dx.doi.org/10.1155/2020/4121483

Ejemplares similares

Herbal Formula Shenling Baizhu San for Chronic Diarrhea in Adults: A Systematic Review and Meta-analysis
por: Wang, Hui, et al.
Publicado: (2022)

Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice
por: Yao, Zheng, et al.
Publicado: (2023)

A Network Pharmacology-Based Study on Irritable Bowel Syndrome Prevention and Treatment Utilizing Shenling Baizhu Powder
por: Meng, Meng, et al.
Publicado: (2021)

Effect of Shenling Baizhu powder on immunity to diarrheal disease: A systematic review and meta-analysis
por: Chen, Qian, et al.
Publicado: (2022)

Prevention of polycystic ovary syndrome and postmenopausal osteoporosis by inhibiting apoptosis with Shenling Baizhu powder compound
por: Liang, Jing, et al.
Publicado: (2022)

Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats
por: Deng, Yuanjun, et al.
Publicado: (2019)

Effects of Shenling Baizhu powder on pyrotinib-induced diarrhea: analysis of gut microbiota, metabonomics, and network pharmacology
por: Lai, Jingjiang, et al.
Publicado: (2022)

Effects of ShenLing BaiZhu San Supplementation on Gut Microbiota and Oxidative Stress in Rats with Ulcerative Colitis
por: Gu, Daxing, et al.
Publicado: (2021)

Effect of Shenling Baizhu San on Intestinal Flora in a Rat Model of Ulcerative Colitis with Spleen Deficiency and Dampness
por: Luo, Yiting, et al.
Publicado: (2022)

Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c
por: Tang, Kairui, et al.
Publicado: (2020)

Traditional Chinese medicine prescription Shenling BaiZhu powder to treat ulcerative colitis: Clinical evidence and potential mechanisms
por: Chen, Jing, et al.
Publicado: (2022)

Effects of Lactobacillus plantarum fermented Shenling Baizhu San on gut microbiota, antioxidant capacity, and intestinal barrier function of yellow-plumed broilers
por: Lv, Weijie, et al.
Publicado: (2023)

Shenling Baizhu San supresses colitis associated colorectal cancer through inhibition of epithelial-mesenchymal transition and myeloid-derived suppressor infiltration
por: Lin, Xiaochang, et al.
Publicado: (2015)

Quantitative proteomics analysis based on data-independent acquisition reveals the effect of Shenling Baizhu powder (SLP) on protein expression in MAFLD rat liver tissue
por: Song, Sufei, et al.
Publicado: (2023)

Chinese Herbal Medicine Formula Shenling Baizhu San Ameliorates High-Fat Diet-Induced NAFLD in Rats by Modulating Hepatic MicroRNA Expression Profiles
por: Pan, Maoxing, et al.
Publicado: (2019)

Knockdown of TFRC suppressed the progression of nasopharyngeal carcinoma by downregulating the PI3K/Akt/mTOR pathway
por: Feng, Guofei, et al.
Publicado: (2023)

Shenling Baizhu Powder Alleviates TNBS-Induced Colitis in Rats by Improving Intestinal Epithelial Permeability and Inhibiting Inflammation Through the TLR5/MyD88/NF-κB Pathway
por: Rao, Kehan, et al.
Publicado: (2022)

Evaluation of the teratogenic effects of three traditional Chinese medicines, Si Jun Zi Tang, Liu Jun Zi Tang and Shenling Baizhu San, during zebrafish pronephros development
por: Ding, Yu-Ju, et al.
Publicado: (2015)

Shenling Baizhu Powder Inhibits RV-SA11-Induced Inflammation and Rotavirus Enteritis via TLR4/MyD88/NF-κB Signaling Pathway
por: Wang, Xiaoyan, et al.
Publicado: (2021)

Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway
por: Yin, Feng, et al.
Publicado: (2021)

The protective effect of Apelin-13 against cardiac hypertrophy through activating the PI3K-AKT-mTOR signaling pathway
por: Peng, Yu, et al.
Publicado: (2023)

PI3K/AKT/mTOR Pathway in Angiogenesis
por: Karar, Jayashree, et al.
Publicado: (2011)

The PI3K-AKT-mTOR pathway activates recovery from general anesthesia
por: Zhang, Yun-Hui, et al.
Publicado: (2016)

The PI3K-Akt-mTOR pathway mediates renal pericyte-myofibroblast transition by enhancing glycolysis through HKII
por: Chen, Liangmei, et al.
Publicado: (2023)

Mingmu Xiaoyao granules regulate the PI3K/Akt/mTOR signaling pathway to reduce anxiety and depression and reverse retinal abnormalities in rats
por: Ma, Qiuyan, et al.
Publicado: (2022)

A randomized controlled trial for the effect of Modified Shenling Baizhu Powder on delaying the illness progress of COPD stable phase patients (GOLD 1–2 stages): A study protocol
por: Liu, Yufei, et al.
Publicado: (2020)

Putative functional variants of PI3K/AKT/mTOR pathway are associated with knee osteoarthritis susceptibility
por: Wang, Kejie, et al.
Publicado: (2020)

PI3K-Akt-mTOR inhibition by GNE-477 inhibits renal cell carcinoma cell growth in vitro and in vivo
por: Ye, Xueting, et al.
Publicado: (2020)

Ligustrazine protects against chronic hypertensive glaucoma in rats by inhibiting autophagy via the PI3K-Akt/mTOR pathway
por: Du, Hong-yan, et al.
Publicado: (2021)

Neuroinflammation and central PI3K/Akt/mTOR signal pathway contribute to bone cancer pain
por: Zhang, Jian, et al.
Publicado: (2019)

MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway
por: Su, Wei, et al.
Publicado: (2022)

Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence
por: Darici, Salihanur, et al.
Publicado: (2020)

Targeting PI3K/Akt/mTOR Signaling in Cancer
por: Porta, Camillo, et al.
Publicado: (2014)

PI3K/Akt/mTOR inhibitors in breast cancer
por: Lee, Joycelyn JX, et al.
Publicado: (2015)

The PI3K/AKT/mTOR Signaling Pathway Is Overactivated in Primary Aldosteronism
por: Su, Hengchuan, et al.
Publicado: (2013)

TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells
por: Weng, Huixi, et al.
Publicado: (2021)

Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway
por: Feng, Tingting, et al.
Publicado: (2016)

Propofol postpones colorectal cancer development through circ_0026344/miR-645/Akt/mTOR signal pathway
por: Cui, Xiaomin, et al.
Publicado: (2021)

Chelerythrine Inhibits Stemness of Cancer Stem-Like Cells of Osteosarcoma and PI3K/AKT/mTOR Signal
por: Chen, Zhixing, et al.
Publicado: (2022)

Simultaneous Determination of Ten Bioactive Components from Shenling Baizhu San in Rat Plasma by UHPLC-MS/MS: Application to a Comparative Pharmacokinetic Study in Normal and Two Models of Ulcerative Colitis Rats
por: Xu, Xia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qe31hq44asqkbn049r3esvrp74